Aquestive Therapeutics Inc (AQST)
3.06
-0.01
(-0.33%)
USD |
NASDAQ |
May 24, 16:00
3.06
0.00 (0.00%)
After-Hours: 19:53
Aquestive Therapeutics Free Cash Flow: -26.60M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -26.60M |
| December 31, 2023 | -7.375M |
| September 30, 2023 | 5.973M |
| June 30, 2023 | 9.563M |
| March 31, 2023 | 11.06M |
| December 31, 2022 | -12.34M |
| September 30, 2022 | -29.33M |
| June 30, 2022 | -39.57M |
| March 31, 2022 | -34.28M |
| December 31, 2021 | -33.89M |
| September 30, 2021 | -39.05M |
| June 30, 2021 | -38.25M |
| March 31, 2021 | -46.41M |
| Date | Value |
|---|---|
| December 31, 2020 | -45.98M |
| September 30, 2020 | -42.89M |
| June 30, 2020 | -49.42M |
| March 31, 2020 | -56.58M |
| December 31, 2019 | -60.87M |
| September 30, 2019 | -53.51M |
| June 30, 2019 | -50.56M |
| March 31, 2019 | -33.40M |
| December 31, 2018 | -14.82M |
| September 30, 2018 | -19.01M |
| June 30, 2018 | 8.107M |
| March 31, 2018 | 1.031M |
| December 31, 2017 | 3.756M |
Free Cash Flow Range, Past 5 Years
-60.87M
Minimum
Dec 2019
11.06M
Maximum
Mar 2023
-32.02M
Average
-38.65M
Median
Free Cash Flow Benchmarks
| Lifecore Biomedical Inc | -- |
| Harrow Inc | -14.27M |
| Akebia Therapeutics Inc | -25.28M |
| 89bio Inc | -138.82M |
| Humacyte Inc | -83.53M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -10.38M |
| Cash from Investing (Quarterly) | -0.029M |
| Cash from Financing (Quarterly) | 81.74M |
| Free Cash Flow Per Share (Quarterly) | -0.1415 |
| Free Cash Flow to Equity (Quarterly) | -11.66M |
| Free Cash Flow to Firm (Quarterly) | -6.542M |
| Free Cash Flow Yield | -13.23% |